Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 3OTHER 1NETWORK 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 20Lymphoma 19Lymphoma, Large B-Cell, Diffuse 17Hodgkin Disease 8Lymphoma, Non-Hodgkin 7Lymphoma, Follicular 5Leukemia 5Hemangioma 5Lymphoma, Large-Cell, Anaplastic 4Prostatic Neoplasms 3Neoplasms 3Lymphoma, B-Cell 3Immunoblastic Lymphadenopathy 3Neurotoxicity Syndromes 2Neoplasm, Residual 2Lymphoma, T-Cell, Peripheral 2Lymphoma, T-Cell 2Lymphoma, Mantle-Cell 2Lymphoma, B-Cell, Marginal Zone 2Esophageal Stenosis 2Enteropathy-Associated T-Cell Lymphoma 2Vomiting 1Thymoma 1Recurrence 1Pulmonary Disease, Chronic Obstructive 1Polycystic Ovary Syndrome 1Philadelphia Chromosome 1Neoplasm Metastasis 1Neoadjuvant Therapy 1Nausea 1

Interventions

Cyclophosphamide 115Dexamethasone 70fludarabine phosphate 57Cytarabine 56fludarabine 52Rituximab 51Peripheral Blood Stem Cell Transplantation 40Etoposide 40Gemcitabine 39Lenalidomide 38pembrolizumab 33Radiotherapy 33Busulfan 33Filgrastim 32Carboplatin 31Methotrexate 30Cyclosporine 29Cisplatin 29Bortezomib 29Mycophenolic Acid 28Melphalan 28venetoclax 27Paclitaxel 26Whole-Body Irradiation 24Antilymphocyte Serum 23Temozolomide 22Granulocyte Colony-Stimulating Factor 20Calcium Dobesilate 20Bevacizumab 20Tacrolimus 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Recurrence × Prednisolone × Clear all
NCT01068392 2014-11-04

Oxaliplatin and Prednisolone (Ox-P) for Patients With Relapsed or Refractory Marginal Zone B-cell Lymphoma(MZL)

Dong-A University Hospital

Phase 2 Completed
42 enrolled
Lymphoid

Recurrence, Lymphoma, B-Cell, Lymphoma, B-Cell, Marginal Zone

Data powered by HemOnc (CC BY 4.0) Colophon âš¡